HADHB and acute myeloid leukemia: In recent years, extensive reports have demonstrated the tumour suppressing roles of HADHB in various cancers, such as colorectal cancer (CRC), oral squamous cell carcinoma (OSCC), and acute myeloid leukaemia (AML) (15–17).